Ray Oomen

449 total citations
7 papers, 340 citations indexed

About

Ray Oomen is a scholar working on Molecular Biology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ray Oomen has authored 7 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Epidemiology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ray Oomen's work include vaccines and immunoinformatics approaches (2 papers), Immunotherapy and Immune Responses (2 papers) and RNA and protein synthesis mechanisms (2 papers). Ray Oomen is often cited by papers focused on vaccines and immunoinformatics approaches (2 papers), Immunotherapy and Immune Responses (2 papers) and RNA and protein synthesis mechanisms (2 papers). Ray Oomen collaborates with scholars based in United States, Canada and Australia. Ray Oomen's co-authors include Pamela Dunn, Mark Parrington, Kurt Gish, James Tartaglia, Kevin W.H. Kwok, Deon J. Venter, Jane E. Armes, Jalil Hakimi, Laszlo Radvanyi and Neil L. Berinstein and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Scientific Reports.

In The Last Decade

Ray Oomen

7 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ray Oomen United States 6 153 85 64 59 54 7 340
Matthew Blades United Kingdom 8 247 1.6× 108 1.3× 37 0.6× 62 1.1× 20 0.4× 16 445
Jyoti Asundi United States 9 165 1.1× 162 1.9× 81 1.3× 83 1.4× 38 0.7× 11 426
Nelly Leung Canada 11 186 1.2× 55 0.6× 102 1.6× 45 0.8× 115 2.1× 12 458
Divyendu Singh United States 10 217 1.4× 138 1.6× 69 1.1× 67 1.1× 244 4.5× 10 481
M. Beitsma Netherlands 14 177 1.2× 64 0.8× 40 0.6× 19 0.3× 45 0.8× 25 476
Haodi Dong China 8 128 0.8× 56 0.7× 33 0.5× 31 0.5× 47 0.9× 13 263
Rosa T. Sterk United States 7 248 1.6× 125 1.5× 80 1.3× 12 0.2× 50 0.9× 9 395
Zehui Lei China 11 283 1.8× 119 1.4× 25 0.4× 20 0.3× 124 2.3× 20 478
Phillip Heaton United States 9 258 1.7× 86 1.0× 92 1.4× 10 0.2× 59 1.1× 13 390
Anne‐Sophie W. Møller Norway 10 129 0.8× 68 0.8× 185 2.9× 64 1.1× 150 2.8× 16 405

Countries citing papers authored by Ray Oomen

Since Specialization
Citations

This map shows the geographic impact of Ray Oomen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ray Oomen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ray Oomen more than expected).

Fields of papers citing papers by Ray Oomen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ray Oomen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ray Oomen. The network helps show where Ray Oomen may publish in the future.

Co-authorship network of co-authors of Ray Oomen

This figure shows the co-authorship network connecting the top 25 collaborators of Ray Oomen. A scholar is included among the top collaborators of Ray Oomen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ray Oomen. Ray Oomen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
2.
Giel–Moloney, Maryann, Ana P. Goncalvez, John Catalan, et al.. (2018). Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine. Scientific Reports. 8(1). 13206–13206. 31 indexed citations
3.
Ahmad, Rushdy, Kathleen D. Press, Amanda K. Lukens, et al.. (2017). Quantitative Proteomic Profiling Reveals Novel Plasmodium falciparum Surface Antigens and Possible Vaccine Candidates. Molecular & Cellular Proteomics. 17(1). 43–60. 23 indexed citations
4.
Radvanyi, Laszlo, Gustavo V. Mallo, Kurt Gish, et al.. (2005). The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. Proceedings of the National Academy of Sciences. 102(31). 11005–11010. 183 indexed citations
5.
Sodoyer, Régis, Bruno Guy, Nicolas Burdin, et al.. (2002). Nouveaux vaccins à l'ère post-génomique. 12. 119–133. 1 indexed citations
6.
Murdin, Andrew D., Pamela Dunn, Régis Sodoyer, et al.. (2000). Use of a Mouse Lung Challenge Model to Identify Antigens Protective againstChlamydia pneumoniaeLung Infection. The Journal of Infectious Diseases. 181(s3). S544–S551. 41 indexed citations
7.
Loosmore, Sheena M., et al.. (1998). The Haemophilus influenzae HtrA Protein Is a Protective Antigen. Infection and Immunity. 66(3). 899–906. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026